Ascletis Pharma announces first dosing of HBV patient in ASC22 trial

China |  News | 0 Comment | 17 Aug, 2020

China-based Ascletis Pharma Inc. recently announced the dosing of the first HBV patient in Phase IIa clinical trial of A...Read more

CUHK study suggests Hot Nights pose greater threat to public health than Hot Days

China |  News | 0 Comment | 17 Aug, 2020

Hong Kong has been experiencing hotter summers and more scorcher days in recent years due to climate change and heat isl...Read more

CanSinoBIO lists successfully on STAR Market as Initial dual listing vaccine company

China |  News | 0 Comment | 14 Aug, 2020

China's CanSino Biologics Inc. announced on 13 August 2020 that it has successfully listed on the Sci-Tech Innovati...Read more

Viva Biotech acquires major stake in Chinese CDMO

China |  News | 0 Comment | 14 Aug, 2020

Viva Biotech (Shanghai) Co., Ltd. has entered into the Share Purchase Agreement pursuant to which Viva Biotech agreed to...Read more

Antengene announces approval of first Ph I Trial of ATG-017

China |  News | 0 Comment | 13 Aug, 2020

Shanghai-based Antengene Corporation, leading innovative hematology and oncology-focused biopharmaceutical company, anno...Read more

SCMP’s China Healthcare Report reveals World’s Second-Largest Healthcare Market

China |  News | 0 Comment | 13 Aug, 2020

South China Morning Post announced on 13 August 2020 the release of its inaugural China Healthcare Report that...Read more

Innovent & Lilly announce acceptance of new drug application for TYVYT® (sintilimab injection)

China |  News | 0 Comment | 12 Aug, 2020

China-based Innovent Biologics, Inc. (Innovent), jointly announced with Eli Lilly and Company (Lilly) that the National ...Read more

LianBio to extend cutting-edge therapeutics in China and major Asian market

China |  News | 0 Comment | 12 Aug, 2020

LianBio, founded, seeded and incubated by Perceptive Advisors, announced its launch on 11 August 2020 with a diverse arr...Read more

Asclepius Meditec's hydrogen/oxygen generator helps improve COVID-19 severity

China |  News | 0 Comment | 11 Aug, 2020

An innovative, environmentally friendly treatment with no side effects has been made available to COVID-19 patients, inv...Read more

Hong Kong discovers liver injury in COVID-19 patients

China |  News | 0 Comment | 12 Aug, 2020

Researchers from the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) have recently conducted a ...Read more

Innovent & Lilly release clinical trial results of sintilimab injection

China |  News | 0 Comment | 10 Aug, 2020

China-based Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical company that develops, manufactures and...Read more

Regulations and geopolitics themes for Japanese companies to reduce dependence on China

China |  Analysis | 0 Comment | 07 Aug, 2020

Regulations, China Impact and Geopolitics were the top themes in 2020 for Japanese companies to reduce dependency on Chi...Read more

ImmVira, Shanghai Pharma to commercialize novel immunotherapies

China |  News | 1 Comment | 07 Aug, 2020

ImmVira Group Company and Shanghai Pharmaceuticals Holding Co., Ltd recently announced a clinical collaboration and excl...Read more

AstraZeneca inks COVID-19 vaccine deal with China's BioKangtai

China |  News | 0 Comment | 07 Aug, 2020

AstraZeneca signed a deal with Beijing-based Shenzhen Kangtai Biological Products (BioKangtai) ...Read more

HBM collaborates with Viva Biotech to promote biotech start-ups

China |  News | 0 Comment | 05 Aug, 2020

  Harbour BioMed (HBM), a global clinical-stage biopharmaceutical company based in the US and Shanghai-based Viva ...Read more

G1, Simcere to bring new cancer therapy in Greater China

China |  News | 0 Comment | 06 Aug, 2020

US based G1 Therapeutics, Inc., a clinical-stage oncology company, and Simcere Pharmaceutical Group, a pharmaceutic...Read more

Innovent announces first patient dosed in Ph 1 clinical trial of bispecific antibody

China |  News | 0 Comment | 03 Aug, 2020

Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical Chinese company that develops, manufactures and com...Read more

Gan & Lee launches first Ph I clinical trial for new anti-tumor drug

China |  News | 0 Comment | 31 Jul, 2020

Recently, Chinese company Gan & Lee Pharmaceuticals Co., Ltd. (Gan & Lee), has launched their first Phase 1 huma...Read more